|
| 37310549 | Gut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls. | J Gastrointest Cancer | 2024 |
| 36315911 | Reply to S. Raoof. | J Clin Oncol | 2023 |
| 35636921 | Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. | Gut | 2023 |
| 37219942 | High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer. | JCI Insight | 2023 |
| 36993185 | Big Advocacy, Little Recognition: The Hidden Work of Black Patients in Precision Medicine. | Res Sq | 2023 |
| 37184135 | The role of area-level socioeconomic disadvantage in racial disparities in cancer incidence in metropolitan Detroit. | Cancer Med | 2023 |
| 36723416 | Area-level Socioeconomic Disadvantage and Cancer Survival in Metropolitan Detroit. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36549838 | Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. | Clin Gastroenterol Hepatol | 2023 |
| 36549470 | Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines. | Clin Gastroenterol Hepatol | 2023 |
| 36808717 | Psychosocial factors impacting barriers and motivators to cancer genetic testing. | Cancer Med | 2023 |
| 36871600 | Assessing Risk for Gastrointestinal Cancers: Forewarned Is Forearmed⿦˿. | Gastroenterology | 2023 |
| 36804602 | Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. | Gastroenterology | 2023 |
| 36765432 | The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial. | Trials | 2023 |
| 36529467 | Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. | Gastroenterology | 2023 |
| 33359728 | Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer. | Clin Gastroenterol Hepatol | 2022 |
| 35704792 | The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival. | J Clin Oncol | 2022 |
| 35930793 | Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer. | J Urol | 2022 |
| 35984085 | Reply by Authors. | J Urol | 2022 |
| 36087100 | Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. | Am J Gastroenterol | 2022 |
| 35183359 | American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review of evidence. | Gastrointest Endosc | 2022 |
| 35183358 | ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. | Gastrointest Endosc | 2022 |
| 35001450 | Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. | J Genet Couns | 2022 |
| 35197584 | Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential. | Br J Cancer | 2022 |
| 34708320 | Correction to: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations. | Fam Cancer | 2022 |
| 34545504 | Outcomes of retesting in patients with previously uninformative cancer genetics evaluations. | Fam Cancer | 2022 |
| 34798986 | Identification of Lynch Syndrome. | Gastrointest Endosc Clin N Am | 2022 |
| 34678218 | Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. | Gastroenterology | 2022 |
| 34261858 | Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial. | Dis Colon Rectum | 2022 |
| 32641470 | Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. | Gut | 2021 |
| 33630025 | Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors. | JAMA Oncol | 2021 |
| 33926820 | COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals. | Pancreatology | 2021 |
| 33925893 | Disparities in Early-Onset Colorectal Cancer. | Cells | 2021 |
| 33724754 | Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2021 |
| 34607877 | Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Letter. | Cancer Prev Res (Phila) | 2021 |
| 33982955 | Dye-Based Chromoendoscopy in Patients With Lynch Syndrome: An Individual Patient Data Meta-Analysis of Randomized Trials. | Am J Gastroenterol | 2021 |
| 34280438 | Initial Findings from a High Genetic Risk Prostate Cancer Clinic. | Urology | 2021 |
| 32889149 | To Biopsy or Not to Biopsy the Papilla? Just One of Many Questions in Surveillance of Patients With Familial Adenomatous Polyposis. | Clin Gastroenterol Hepatol | 2021 |
| 31394082 | Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. | Gastroenterology | 2020 |
| 31756137 | Current Approaches to Germline Cancer Genetic Testing. | Annu Rev Med | 2020 |
| 32051178 | A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. | Cancer Prev Res (Phila) | 2020 |
| 33027290 | Co-morbid risk factors and NSAID use among white and black Americans that predicts overall survival from diagnosed colon cancer. | PLoS One | 2020 |
| 33005238 | <i>Fusobacterium nucleatum</i> infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage. | Gut Pathog | 2020 |
| 32637605 | XAF1 as a modifier of p53 function and cancer susceptibility. | Sci Adv | 2020 |
| 32634771 | NCCN Guidelines Insights: Rectal Cancer, Version 6.2020. | J Natl Compr Canc Netw | 2020 |
| 32905675 | Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. | N Engl J Med | 2020 |
| 32500284 | Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers. | Dig Dis Sci | 2020 |
| 32251017 | Family History of Colorectal or Esophageal Cancer in Barrett's Esophagus and Potentially Explanatory Genetic Variants. | Clin Transl Gastroenterol | 2020 |
| 30584801 | Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. | J Pathol | 2019 |
| 31469826 | A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene. | PLoS Genet | 2019 |
| 31232912 | Genomic Profiling of Vulvar Lichen Sclerosus Patients Shows Possible Pathogenetic Disease Mechanisms. | J Low Genit Tract Dis | 2019 |